A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Doing a certain amount of exercise is linked to a 30% to 40% lower risk of an early death from any cause, according to a new ...

In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

Dr. Carrie Jose, in her latest Health and Wellness column, explains what you need to know before you try Platelet-Rich Plasma ...

Of 1.3 million participants in the MWS with a median follow-up of 21.4 years, 2,765 (o.21%) developed liver cancer, with no ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

By Vijay Kumar MalesuResearchers find that both current and former e-cigarette users face elevated odds of chronic lung ...

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

In recent years, the application of picosecond laser (PSL) treatment for skin discoloration caused by nevus of Ota has been ...

Doctors are at higher risk of depression, anxiety and suicide than almost any other profession. Now, a global review led by ...

Researchers from the University of Maryland's Department of Nutrition and Food Science are shedding new light on how a ...